An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

This study will examine the effect of BIIB021 on GIST growth and metabolism.

Phase 2

Biogen